The medical applications of Cordyceps are centered primarily on the key functions of different organs, including but not limited to  lung, kidney, liver and heart. Cordyceps is also recommended as an aid to treatment of cancer, diabetes and organ transplant. Identified benignant elements such as adenosine, cordycepin, cordycepic acid, the polysaccharides and vitamins and trace elements, are believed to be partially the cause of the well-known effects.

While scientists are still in search of more key components of the fungus, numerous clinical trials have proceeded to scientifically prove that Cordyceps works well in treating and healing a myriad of medical problems. Select a topic below to read more clinical study details.

 

Kidney Lung Heart Liver Diabetes Anti-aging High Cholesterol Cancer Reduce Drug Toxicity

Kidney

Modern science has confirmed that kidney health is indeed the most important of the body's health. Kidneys failure is oftentimes the source of the problems occurring to other organs and systems, leading to various diseases and ailment. Fatigue, impotence, joint and back pain, even ringing in the ears are all symptoms of degenerative kidney health. In 1998, Dr Zhou and his team discovered that much of Cordyceps kidney enhancing potential comes from its ability to increase 17-hydroxy-corticosteroid and 17-ketosteriod levels. Many other traditional uses for the fungus can be traced back to proper kidney health.

Chronic renal failure is a serious disease affecting the elderly. In a 1992 study of 51 patients with chronic renal failure, Dr. Guan and his colleagues found that the group of patients receiving 3-5 grams per day of Cordyceps Sinensis had shown significantly improved kidney function and overall immune function, as compared to the placebo group.

Patients with kidney problems often suffer from hypertension, proteinuria and anemia. In a study with such patients it was found that after one month on Cordyceps, a 15% reduction in blood pressure was observed. Urinary protein was also significantly reduced. Additionally, increase in superoxide dismutase was documented. The study further suggests an increase in the oxygen free radical scavenging capacity, resulting in reduced oxidative cellular damage.

In another clinical study, 57 patients with gentamicin-induced kidney damage were either treated with 4.5 grams of Cordyceps per day or by other, more conventional methods. After six days, the group that received Cordyceps had recovered 89% of their normal kidney function; while the control group had recovered only 45% of normal kidney function. The time-to-recovery was also significantly shorter in the Cordyceps group when compared to the control group

Lung

In China, Cordyceps has been viewed as a promoter of respiratory health for more than a thousand years. Cordyceps is known to enhance oxygen utilization and cellular oxygen uptake. This benefits the entire body with more energy and vitality.

In environments with low oxygen levels, mice treated with Cordyceps were able to survive up to three times longer than those left untreated, evidencing more efficient oxygen utilization. This is confirmed by Cordyceps' long history of use in preventing and treating altitude sickness.

Cordyceps has been used effectively to treat Bronchitis, Asthma, and Chronic Obstructive Pulmonary Disease (COPD). Cordyceps Sinensis has been shown to inhibit tracheal contractions, especially important for asthma patients in that it allows for increased airflow to the lungs. In addition, its anti-inflammatory properties bring further relief to asthma patients, whose airways become obstructed, due to an allergic reaction resulting in swelling of the bronchial pathways. In a clinical trial involving 50 asthma patients, efficacy against symptoms among the group treated with Cordyceps was 81.3%, within an average of five days; while among those treated with conventional antihistamines the rate was only 61.1%, and took an average of nine days for symptoms to subside.

There has been very extensive trails in humans, using Cordyceps to treat all manner of respiratory illnesses, including asthma, COPD, and bronchitis, either alone or as an adjunct to standard antibiotic therapy. It has proven useful for all of these conditions. What has been observed for centuries by thousands of TCM practitioners, that Cordyceps improves respiratory function, is now a well-proven and well-accepted scientific fact.

Heart

One of the most important benefits of Cordyceps is its ability to stabilize the heart beat and correct heart arrhythmias. This fungus is on top of the list of choices for this serious condition in China today. Exact mechanism is only partly understood. One study pointed to the presence of adenosine. Cordyceps contains a significant amount of adenosine, deoxyadenosine and related adenosine type nucleotides. Those compounds have great impact on coronary and cerebral circulation.

Cordyceps doesn't interfere with any other arrhythmia medication. With low toxicity, Cordyceps has become an excellent choice for this condition.

Cordyceps has been used traditionally for many other heart diseases. It benefits the vascular system by improving circulation, regulating blood pressure, and strengthening the heart muscle.

In a long-term study of patients with chronic heart failure, continuous use of Cordyceps in combination with conventional treatments promoted an increase in the overall quality of life. This included general physical condition, mental health, and cardiac function, compared to the control group.

Liver

Protecting liver and kidneys. Cordyceps improves blood flow to these organs (as well as to the others), which results in their better activity and ability to fight the diseases, including Hepatitis and chronic kidney disease.

Large amount of research has been done on Cordyceps' benefits on liver function. Nearly all such studies confirmed that Cordyceps enhances liver function. Cordyceps is commonly used as an adjunct in the treatment of Hepatitis B and C.

In one study, Cordyceps was used with lamivudine for the treatment of Hepatitis B. The group receiving Cordyceps had a much better outcome in a shorter period of time than the control group who received only the lamivudine.

In another study of 22 patients with post hepatic cirrhosis, all patients showed dramatic improvement in liver function tests, after 3 months of 6-9 grams of Cordyceps daily.

Diabetes

Another area where there has been a lot of research done is in the effect of Cordyceps on the blood glucose metabolism system. Diabetes is a serious problem, especially in countries with a Western diet.

Cordyceps has been tested in a number of animal and human studies for its potential as a blood sugar regulation agent. The results are very promising. In one clinical study, 95% of the patients treated with 3 grams Cordyceps daily saw improvement in their blood sugar measurement, while the control group showed only 54% improvement with traditional treatment.

In one animal trial by Kiho in 2000, Cordyceps was found to lower blood sugar levels in genetically diabetic animals. Another animal trial by Dr. Zhao and his team in 2002 showed that Cordyceps improves blood glucose metabolism and increases insulin sensitivity in normal animals. In another 2002 animal study by Hao and Chen concluded that Cordyceps positively affect blood sugar metabolism in animals with chemically induced diabetes. The common thread throughout all of these trials is the increase in insulin sensitivity and the increase in the livers' output of the glucose regulating enzymes. In short, it appears that regardless of the cause or classification, Cordyceps is a great treatment for diabetes, either as a single agent or in conjunction with other drugs.

In one clinical study, non-diabetic patients were treated with 3 grams Cordyceps daily. Researchers found that the normal blood sugar change curve was significantly flattened in the Cordyceps group. In other words, the blood sugar did not go as high after eating, and it did not drop down as low between meals. This study again proved that Cordyceps has the ability to regulate blood sugar level.

Anti-aging

One instantly noticeable benefit of Cordyceps is that it provides anti-aging and fatigue reducing effects. The fungus works as an antioxidant and increases cellular formation, especially in the seniors. It also promotes more restful sleep, soothes the nervous system, and reduces anxiety. Cordyceps is commonly used as an overall rejuvenator for patients recovering from serious illness.

Aging is the direct result of body's declining ability to obtain and use oxygen. In a recent study, Dr. Guo confirmed that Cordyceps usage increase the cellular ATP level. ATP (adenosine triphosphate) is the compound that consumes oxygen and releases energy in the cell. An increase in cellular ATP means a real increase in actual energy, energy that is available for use. This contrasts to the perceived increase in energy such as that which occurs from the use of CNS stimulants such as caffeine, ephedrine and the amphetamines. Another 2004 study by Dr. Zhu, showed that Cordyceps enhances oxygen utilization.

High Cholesterol

Hypercholesterolemia is a clear indicator of dysfunction of the metabolism and an indicator of increased cardiovascular risk. The liver is the main source of both cholesterol production and elimination; therefore it stands to reason that any disorders of the liver could affect the blood levels of cholesterol and triglyceride. It is also well known that diabetes can and usually does lead to hyperlipidemia.

Cordyceps is well proven through many formal trials and clinical observations to act in a positive way with regards to maintaining healthy cholesterol and triglyceride levels. In both human and animal studies, administration of Cordyceps has been associated with cholesterol and triglyceride reduction and an increase in ratio of HDL to LDL cholesterol.

Cancer

One of the most promising benefits of Cordyceps is its anti-cancer effect. More and more doctors worldwide recommend Cordyceps as an alternative, or addition to chemotherapy, radiation and other traditional cancer treatments. It has been used successfully to stop the growth of cancer cells, and to dissolve cancerous tumors. Clinical studies have proven that Cordyceps has the ability to enhance and strengthen the immune system. It helps the body to more efficiently manage its immune resources while undergoing the stresses of the attack by cancer.

This secondary effect is extremely important for patients going through chemotherapy or radiation treatment, in that it keeps body strong against the side effects of those treatments. It is no longer a secret that many more patients die of opportunistic infections during chemotherapy than ever die of the cancer itself. The use of Cordyceps will minimize the risk of complication.

Many clinical studies have shown positive results. In one study, fifty patients with lung cancer were given 6 grams of Cordyceps daily in conjunction with chemotherapy. Tumors were reduced in size in 46% of the patients. A trial involving cancer patients with several different types of tumors found that Cordyceps taken over a two month period at 6 grams a day, improved subjective symptoms in majority of the patients. White blood cell counts were kept high while tumor size was significantly reduced in approximately half of the patients.

Reduce Drug Toxicity

Many popular drugs have quite considerable toxicity, and it is hoped that the incorporation of Cordyceps into the treatment regimen of those patients undergoing such therapy might result in a reduction of some of these more toxic synthetic drugs, while sacrificing none of the efficacy.

Organ transplant is a good example of how Cordyceps can be used in conjunction with drugs. Cyclosporin is a well-known drug for organ transplant. The problem is its toxicity. Many patients suffer from serious kidney damage after using Cyclosporin. In a 1995 clinical study, 69 kidney transplant patients were given either Cyclosporin alone, or in conjunction with Cordyceps Sinensis at 3 grams a day. After 15 days it was clearly evident that the group receiving Cordyceps Sinensis in addition to the Cyclosporin had a much lower incidence of kidney failure than the group receiving only the Cyclosporin.

Ready to order? Go directly to our online store. Open 24 hours a day, 7 days a week. Money back is guaranteed.

References

Jia-Shi Zhu, M.D., Ph.D. and James Rippe, M.D. (2004) Presented at the American Physiological Society's (APS) annual scientific conference, Experimental Biology 2003, held April 17-21, 2004, in Washington, D.C.

Shin KH, Lim SS, Lee S, Lee YS, Jung SH, Cho SY. (2003) Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res. 2003 Aug; 17(7):830-3.

Koh JH, Yu KW, Suh HJ, Choi YM, Ahn TS. (2002) Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem, 2002 Feb; 66(2):407-11.

Smith, Rowen and Sullivan (2002), Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment, May 2002; 106-141.

Hsu T. H., Shiao L. H., Hsiea C., and Chang D. M. 2002. A comparison of the chemical composition and bioactive ingredients of the Chinese medicinal mushroom DongChongXiaCao, its counterfeit and mimic, and fermented mycelium of Cordyceps sinensis. Food Chem, 78:463-469.

Wang, R., Xie, J., Ji, P., Li, S., Zhan, H., Xia, J., Sun, H., Lei, L., Yu, J., Wang, Y., Holliday, J., Clinical Trial report on Chronic Hepatitis treatment using Immune-Assist brand mushroom extract mixture in conjunction with the drug Lamivudine Wasser, S.P., (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 2002; 60:258-274.

Yue-Qin C, Ning W, Hui Z, Liang-Hu Q. (2002) Differentiation of medicinal Cordyceps species by rDNA ITS sequence analysis. Planta Med. 2002 Jul; 68(7):635-9.

Creadon, M. and Dam, J. (1996). " Drink up." Time (August 19): 55. a biologically active compound from cultures mycelia of Cordyceps and Isaria species. Phytochemistry, 22:2509-2512.

Gordon, D. (1993). : The rumored dope on Beijing's Women." Newsweek September 27): 63. Grey, P. and Barker, R. (1993). Cordyceps or plant eats animal! The Victorian Naturalist, 110:98-107.

Guan, Y.J., Hu, G., Hou, M., Jiang, H., Wang, X., and Zhang, C. (1992). Effect of Cordyceps sinensis on T- lymphocyte subsets in chronic renal railure. Chinese Journal of Integrated Medicine, 12:323, 338-339.

Guo, Y. Z. (1986). [Medicinal chemistry, pharmacology and clinical applications of fermented mycelia of Cordyceps sinensis and JinShuBao capsule]. Journal of Modern Diagnostics and Therapeutics, 1:60-65.

Guo QC, Zhang C. (1995) Clinical Observations of Adjunctive Treatment of 20 Diabetic Patients with JinSHuiBao Capsule. J Administration Traditional Chinese Medicine 1995; 5(suppl):22.

Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH., (1999) Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999 Aug; 51(7):891-8.

Chamberlain, M. (1996). Ethnomycological experiences in South West China. Mycologist, 10 (4):173-176.

Chang, H.M. and But, P.P.H. (Eds.) (1986). Pharmacology and Applications of Chinese Materia Medica, 1. Philadelphia, PA: World Scientific, pp. 410-413.

Chen, J.R., Yen, J.H., Lin, C.C., Tsai, W.J., Liu, W.J., Tsai, J.J., Lin, S.F., and Liu, H.W. (1993). The effects of Chinese herbs on improving survival and inhibiting anti-ads DNA antibody production in lupus mice. American Journal of Chinese Medicine, 21:257-262.

Chen K, Li C. (1993) Recent advances in studies on traditional Chinese anti-aging Materia Medica. J Tradit Chin Med 1993 Sep; 13(3):223-6.

Chen, S.Z. and Chu, J.Z. (1996). [NMR an IR studies on the characterization of cordycepin and 2'deoxyadenosine]. Zhongguo Kangshengsu Zaxhi, 21:9-12.

Hammerschmidt, D.E. (1980). Szechwan purpura. New England Journal of Medicine, 302:1191-1193.

Holliday, J., Cleaver, P., Loomis-Powers, M., and Patel, D., Analysis of Quality and Techniques for Hybridization of Medicinal Fungus Cordyceps sinensis, International Journal of Medicinal Mushrooms, Vol. 6, pp. 147-160 (2004).

Huang, Q., Li, D., Liang, J., Liao, S., and Liang S., (1991). [Weak polar chemical components in Cordyceps]. Journal of Chinese Medical Materials, 14:33-34.

Ikumoto, T., Sasaki, S., Namba, H., Toyama, R., Moritoki, H., and Mouri, T. (1991). [Physiologically active compounds in the extracts from tochukaso and cultured mycelia of Cordyceps and Isaria]. Yakugaku Zasshi, 111:504-509.

Huang , Y. et al (1987) Toxicology studies on cultured Cordyceps sinensis strain B414. Zhongchengyao Yanjiu 10:24-25 From Abstracts of Chinese Medicine, 2:321.

Chen, Y.Q., Wang, N., Qu, L., Li., T., and Zhang, W. (2001). Determination of the anamorph of Cordyceps sinensis inferred from the analysis of the ribosomal DNA internal transcribed spacers and 5.85 rDNA. Biochemical Systematics and Ecology, 29:597-607.

Kadota, S., Shima, T., and Kikuchi, T. ( 1986) [Steroidal components of "I-Tiam-Hong" and Cordyceps sinensis. Separation and identification by high-performance liquid chromatography]. Yakugaku Zasshi, 106:1092-1097.

Kiho, T., Tabata , H., Ukai, S., and Hara, C., (1986). A minor protein-containing galactomannan from a sodium carbonate extracted of Cordyceps sinensis. Corbohydrate Reseach, 156:189-197.

Kiho T, Hui J, Yamane A, Ukai S. (1993) Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull 1993 Dec; 16(12):1291-3.

Kiho T, Yamane A, Hui J, Usui S, Ukai S. (2000) Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Phytother Res 2000 Dec; 14(8):647-9.

Kuo, Y.C., Tsai, W.J., Shiao, M.S., Chen, C.F., and Lin, C.Y. (1996) Cordyceps sinensis as an immunomodulatary agent. American Journal of Chinese Medicine, 24:111-125.

Kuo, Y.C., Tsai, W.J., Wang , J.Y., Chang, S.C., Lin, C.Y., and Shiao, M.S. (2001). Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sciences, 68:1067-1082.

Hawksworth D. L., et al. 1995 Ainsworth and Bisbi's Dictionary of the Fungi: 8th ed. International, University Press and Cambridge, 616 pp.

Hirose K., and Yahagi N. 1997. Japan tochukaso, Shock to Disappear of Cancer. Metamoru shyupan, Tokyo, 175 pp.

Itami H., and Yahagi N. 1996. Japan tochukaso, Challenge for Terminal Cancer. Metamoru shyupan, Tokyo, 140pp.

Jiang, JC, Gao, YF. Summary of treatment of 37 chronic renal disfunction patients with JinShuiBao. J Administration Traditional Chinese Med 1995; 5(suppl):23-24.

Kiho T., and Ukai S. 1995. Tochukaso (Semitake and others), Cordyceps species. Food Rev Int, 11, 231-234.

Kiho T., Hui, J., Yamane A., and Ukai S. 1993. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural medium of Cordyceps sinensis. Bio Pharmacol Bull, 16:1291-1293.

Hiho T., Yamane A., Hui J., Usui S., and Ukai S. 1996. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharmacol Bull, 19:294-296.

Kobayashi Y., and Shimizu D., 1983. Iconography of Vegetable Wasps and Plant Worms. Hoikusha Tokyo, 208 pp.

Kubo M. 1996 Tochukaso. Its secret and its Power. Hoikusha,, Tokyo, pp. 128, 152. Li, L.S. and Zheng, F. (1992). Clinical protection of aminoglycoside neophrotoxiciry by Cordyceps sinensis (CS). Journal of the American Society of Nephrology, 3:726 (ABSTRACT 24p).

Liu FA, Zheng X, (1993) Study of Cordyceps sinensis on anti-laryngeal carcinoma. J. Norman Bethune University Med Sci, 1993; 19(1):57-58.

Liu, C., Xue, HM., Xu, LM., Zhao, PZ., Zhang, LB., Tang, MG., Treatment of 22 patients with post hepatic cirrhosis with a preparation of fermented mycelia of Cordyceps sinensis. Shanghai J Chinese Materia Medica, 1986; 6:30-31.

Leung, A.K., Gong, F., and Chau, F. (2000). Analysis of the water soluble constituents of Cordyceps sinensis with heuristic evolving latent projections. Analytical Letters, 33:3195-3211.

The Merck Index, 11 Edition, 1989. 2524 Cordycepin. Merk and Co., 395 pp.

Mizuno T.1997. Development and ultilization of bioactive substances from medical and edible mushrooms fungi (10) Charga, Sclerotiana of Fuscopotia oblique (Fr) Aoshima. The Chemical Times, 163:9-15.

Mizuno T. 1998. Immunological Diet for Cancer Serious Disease. Gendaishorin, Tokyo, 188 pp.

Nakamura K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M., Activation of in-vivo Kupffer cell function by oral administration of Cordyceps sinensis in rats. (1999) Jpn J Pharmacol, 1999 Apr;79(4):505-8.

Nakamura K, Konoha K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. (2003) Combined effects of Cordyceps sinensis and methotrexate on hematogenic lung metastasis in mice. Receptors Channels, 2003; 9(5):329-34 .

Ohmori T., Tamura K., Tsuru S., and Nomoto K., 1986. Antitumor activity of protein-blood polysaccharide from Cordyceps ophioglossoides in mice. Jnp J Cancer Res (Gann), 77:1256-1263.

Ohmori T., Tamura K., Furuki K., Kawanishi G., Mitsuyama M., Nomoto K., Miyazaki t, 1989. Isolation of galactosaminoglycan moity (CO-N) from protein-bound polysaccharide of Cordyceps ophioglossoides and its effects against murine tumor. Chem Pharmacol Bull, 37:1019-1022.

Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G. (2004) Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Apr; 14(2):236-42.

Pelleg, A., Porter, R.S. (1990) The pharmacology of adenosine. Pharmacotherapy, 1990; 10:157-174.

Shin KH, Lim SS, Lee SH, Lee YS, Cho SY (2001) Antioxidant and immunostimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps sp. Ann N Y Acad Sci. 2001 Apr; 928:261-73.

Shimizu D. 1994. Color Iconography of Vegetable Wasps and Plant Worms. Seibundoshinksosha, Tokyo, 381 pp.

Suh SO, Noda H, Blackwell M (2001)Insect symbiosis: derivation of yeast-like endosymbionts within an entomopathogenic filamentous lineage. Mol Biol Evol. 2001 Jun; 18(6):995-1000.

Takeuchi N. 1998. Pharmacological effect of Tochukaso and its utilization for food. Kagaku to Kogyo, 51:1614-161.

Toda, N., Okunishi, H., Taniyama, K., Miyazaki, M., (1982) Response to adenine nucleotides and related compounds of isolated dog cereberal, coronary and mesenteric arteries. Blood Vessels, 1982; 19:226-236.

Ukai S, Kiho T, Hara C, Morita M, Goto A, Imaizumi N, Hasegawa Y (1983) Polysaccharides in fungi: XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia uricula-judae and Auricularia sp. Chem Pharma Bull (Tokyo), 31:741-744.

Yamanaka K., and Inatomi S, 1997. Cultivation of Isaria japonica fruit bodies on mixed plant/insect media. Food Rev Int, 13:455-460.

Segelken, R. (2002) Cyclosporin mold's 'sexual state' found in New York forest Cornell students' discovery could target additional sources of nature-based pharmaceuticals Cornell University Science News, Sept 16, 1996.

Tai-Hao, H., Hui-Chen, L., Biological activity of Cordyceps (Fr.) Link Species (Ascomycetes) Derived from a Natural Source and from Fermented Mycelia on Diabetes in STZ-Induced Rats. Inter J of Med Mush, 4:111-125.

Xu, W.Z., Wei, J.P., Wang N. Q., Liu T., (1988) Experimental study of the combined chemotherapy of Zhiling Capsules and Anticancer agents. Shanghai Zhongyiyao Zazhi 1988; (6):48.

Xu, F., Huang JB., Jiang, L., Xu, J., Mi, J., (1995) Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney transplanted recipients. Nephrol Dial Transplant 1995; 10(1):142-143.

Yamada H., Kawaguchi N., Ohmori T., Takeshita Y., Teneya S., and Miyazaji t. 1984. Structure and antitumor activity if an alkali-soluble polysaccharide from Cordyceps ophioglossoides. Carbohydr Res, 125, 107-115.

Yamaguchi N., et al, (1990) Augmentation of various immune reactivities of tumor bearing hosts with an extract of Cordyceps sinensis. Biotherapy, 2:199-205.

Yang, YZ., Wang, LS., Deng, HY., Ma, YS., Wu, HS., Short term observation of treating chronic hepatitis B and post hepatic cirrhosis with XinGanBao. Res Chinese Materia Medica 1994; 1:19-20.

Yoshida J et al (1989) Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. Against murine tumor cell lines Jpn J Exp Med, 59:157-161.

Zhao CS, Yin WT, Wang JY, Zhang Y, Yu H, Cooper R, Smidt C, Zhu JS. (2002) Cordyceps Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med. 2002 Aug; 8(4):403-5.

Halpern, G., (1999) Cordyceps, Chinas healing mushroom. Avery Publishig 1999: 63-70 Bao, Z.D., Wu, Z.G., and Zheng, F. (1994). [Amelioration of aminoglycoside nephrotoxicity by Cordyceps Sinensis in old patients]. Chinese Journal of Integrated Medicine, 14:259,271-273.

Berne, R.M., 1980: The role of Adenosine in the regulation of coronary blood flow. Circ. Res. 1980; 47:807-813.

Wu T. N., Yang K. C., Wang C. M., Lai J. S., Ko K. N., Chang P. Y., and Liou S. H. 1996. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ, 182, 193-195.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

  Return Policy                                  Terms                                          Privacy

EZorb, EZorb Calcium, and Marvlix are Registered Trademarks of Elixir Industry

Copyright ©2004-2007 EZorbCalcium.com™
Some material provided by Elixir Industry
 All Rights Reserved.

Credit Card
Processing